BioNanoNet is contributing to several working groups that are part of the Austrian Cluster Platform and brings its scientifically based know-how into this platform.
You may find an article about the 5th Austrian Cluster Conference of the National Cluster Platform Austria in our BioNanoNet newsletter 04/2014 on page 23.
BioNanoNet supports the Austrian research community by participating in the national working group and shaping the call topics for European Calls.
The Austrian Nano Information Commission (NIK) is a formal collaboration of stakeholders working in nanotechnology that provides a structured process of communication among experts. It allows them to merge communications in a transparent matter and functions as a contact point for policy makers in order to provide information for courses of action.
In order to hold an unprejudiced discussion about the possible social opportunities and risks of nanotechnologies with respect to their consumer applications, early and open communication is critical. Therefore, the NIK acts as a guide for policy makers and public authorities and allows them to provide advice on nanotechnological issues in Austria. The first course of action was the formal inauguration of the head and members of the NIK by the director of the Federal Ministry of Health, Mr. Alois Stöger, on November 13, 2013, in Vienna. For more details, please see our BioNanonet Newsletter 04/2013 (page 25).
BioNanoNet is permanent member of the NanoInformationsKommission-Plenum group.
BioNanoNet is member of the Management Committee in COST-Action CA15107 MULTICOMP.
MC-Member: Christa Schimpel
MC-Substitute: Susanne Resch
WG3: Characterization, Health, Safety and Environment (HSE)
BioNanoNet is member of the Management Committee in COST-Action TD1402 RADIOMAG.
MC-Member: Christa Schimpel
BioNanoNet is member of the Management Committee in COST-Action CM1403 UPCON.
MC-Member: Andreas Falk
MC-Substitute: Christa Schimpel
The European Society for Nanomedicine is a society of individuals and bodies across Europe that focuses on the clinical application of nanomedicine and its implications for individuals and society. Through this focus, it complements a number of already existing European platforms, initiatives, and framework-programmes that see their main task in linking researchers and industry.
The ETPN is an important European Technology Platform that contributes to the advancement nanomedicine in Europe.
BioNanoNet is member of the Executive Board of the ETPN and co-chair of the working group “Toxicology & Characterisation”, actively contributes to the establishment of the strategic research and innovation agenda of ETPN and helps prepare call topics for future HORIZON 2020-calls (NMP, HEALTH, ICT).
BioNanoNet is coordinator of the Austrian national technology platform NanoMedicine-Austria. Further information: https://www.bionanonet.at/testseite/national-technology-platforms/nanomedicine-austria
BioNanoNet is member of ETPIS.
More information about ETPIS: www.industrialsafety-tp.org/
BioNanoNet is one of the scientific expert members of the European Commission high level group on Nanosciences and Nanotechnologies.
BioNanoNet is member of the General Board of the NANOfutures a.s.b.l. and is a member of several working groups that are part of this network, active world-wide.
All Nanosafety-relevant European projects are connected to each other in the NanoSafetyCluster (NSC). BioNanoNet, as the coordinator of the European Center for Nanotoxicology (EURO-NanoTox), is a partner in the NSC and actively contributes to the NSC-compendium as well as to the strategic research agenda of the NSC.
BioNanoNet is involved as one of Austria`s designated contact points in the "Working Party on Manufactured Nanomaterials" (WPMN).